Biopharmaceuticals are among the most sophisticated and elegant achievements of modern science. The huge, complex structures of these drugs don’t just look extraordinary in the 3-D modeling systems used to design them; they also perform their jobs remarkably well, offering high efficacy and few side effects. And there is much more to come: existing treatment archetypes are evolving and becoming more sophisticated all the time, and continuing research is yielding entirely new types of products.
{iframe}http://www.mckinsey.com/Insights/Health_systems_and_services/Rapid_growth_in_biopharma?cid=other-eml-alt-mip-mck-oth-1412{/iframe}